DULLINGER RONALD

PrivateCIK: 2103871
Location

DURHAM, NC

DULLINGER RONALD enters BIOCRYST PHARMACEUTICALS INC with 258.37K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderDULLINGER RONALDCIK 2103871
Officer· Chief Commercial Officer
Since Jan 2026
258.37K
Baseline shares
100% direct
258.37K
Direct ownership
1 position
678.75K
Derivative underlying
7 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned258.37K
Total
258.37K direct258.37K
Derivative Holdings7

Emp. Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

100K

Shares owned

N/A

Exercise price

8.31

Expiration

Exercise window

Emp. Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

57.10K

Shares owned

N/A

Exercise price

10.63

Expiration

Exercise window

Emp. Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

68.50K

Shares owned

N/A

Exercise price

7.39

Expiration

Exercise window

Emp. Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

57.10K

Shares owned

N/A

Exercise price

6.43

Expiration

Exercise window

Emp. Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

41K

Shares owned

N/A

Exercise price

11.43

Expiration

Exercise window

Emp. Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

255.05K

Shares owned

N/A

Exercise price

7.13

Expiration

Exercise window

Emp. Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

100K

Shares owned

N/A

Exercise price

2.85

Expiration

Exercise window

Total

Underlying

678.75K

Owned

0.00

DULLINGER RONALD — Initial Ownership Disclosure (Form 3) Filed Jan 9, 2026 | Finecho